Best Artificial Intelligence Stocks To Follow Now – August 2nd

Ambarella, Hut 8, and Tempus AI are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of companies that develop, provide, or significantly use AI technologies, such as machine learning, data analytics, robotics, and AI-enabled software or hardware. For stock market investors, these companies may offer growth opportunities tied to increasing AI adoption, but they can also carry heightened risks due to high valuations, intense competition, rapid technological change, and regulatory uncertainty. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

Ambarella (AMBA)

Ambarella, Inc. develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image signal processing, and artificial intelligence processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.

Read Our Latest Research Report on AMBA

Hut 8 (HUT)

Hut 8 Corp., together with its subsidiaries, acquires, builds, manages, and operates data centers for digital assets mining, computing, and artificial intelligence in the United States. It operates in four segments: Digital Assets Mining, Managed Services, High Performance Computing Colocation and Cloud, and Other.

Read Our Latest Research Report on HUT

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read Our Latest Research Report on TEM

Featured Stories